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Background
Human herpesvirus 8 (HHV-8) infection is associated
with the development of primary effusion lymphoma,
Kaposi's sarcoma, and multicentric Castleman's disease.
The K1 gene of HHV-8 is expressed in tumor cells as a
transmembrane protein with an immunoglobulin-like
domain in its ectodomain and an immunoreceptor tyro-
sine-based activation motif (ITAM). We demonstrated
that K1 protein activates nuclear factor-kappa B (NF-κB),
and K1 expression in transgenic mice stimulated accumu-
lation of lymphatic cells and development of lymphoma.
How K1 blocks apoptosis and induces hyperplasia and
lymphomas is not known. We hypothesized that K1 con-
tributes to lymphoma development partly by suppressing
apoptosis, and that this suppression combined with its
NF-κB activation produces lymphoma.
Results
We found that K1 binds to Fas and in turn, inhibits Fas-
mediated apoptosis. We mapped the region that K1 uses
to bind to Fas as an immunoglobulin (Ig) chain-like
domain by expressing deletion mutants of K1. Overex-
pression of an Ig domain-containing protein CD79b com-
peted with K1-Fas binding in a dose-dependent manner.
Two 20-amino acid peptides (N251, N253) representing
the Ig domain of K1 competed with K1-Fas binding in
immunoprecipitation/immunoblotting analysis. The
N251 and N253 peptides (100 μM) enhanced anti-Fas
antibody (CH-11, 50 ng/mL)-induced apoptosis of BJAB
lymphoma cells that expressed K1 but not that of vector-
transfected BJAB cells. Ig-deleted K1 (K1dIg)-transfected
mice were not protected (0/6), and K1-transfected mice
were protected (7/10, P < 0.01) against the lethal effects of
agonistic anti-Fas (Jo2) antibody. K1dIg expressed in mice
did not form complexes with Fas, suggesting that the Ig
domain is essential for K1-Fas binding and suppression of
apoptosis.
Conclusion
Collectively, these results indicate that K1 potently blocks
apoptosis, and that this effect is mediated through the Ig-
like domain of K1. Because viral proteins mimic cellular
proteins, these results predict the presence of functional
cellular homologs of K1 that have key roles in death recep-
tor regulation.
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